"Myelopoiesis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Formation of MYELOID CELLS from the pluripotent HEMATOPOIETIC STEM CELLS in the BONE MARROW via MYELOID STEM CELLS. Myelopoiesis generally refers to the production of leukocytes in blood, such as MONOCYTES and GRANULOCYTES. This process also produces precursor cells for MACROPHAGE and DENDRITIC CELLS found in the lymphoid tissue.
| Descriptor ID |
D038042
|
| MeSH Number(s) |
G04.152.825.597.750 G09.188.343.597.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myelopoiesis".
Below are MeSH descriptors whose meaning is more specific than "Myelopoiesis".
This graph shows the total number of publications written about "Myelopoiesis" by people in this website by year, and whether "Myelopoiesis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Myelopoiesis" by people in Profiles.
-
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021 11; 24(4):755-788.
-
Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism. Front Immunol. 2021; 12:653110.
-
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020 09 17; 182(6):1419-1440.e23.
-
Morphological anomalies of circulating blood cells in COVID-19. Am J Hematol. 2020 07; 95(7):870-872.
-
Regulation of hematopoiesis by the chemokine system. Cytokine. 2018 09; 109:76-80.
-
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Cell. 2018 01 11; 172(1-2):147-161.e12.
-
Can therapeutic drug monitoring increase the safety of Imatinib in GIST patients? Cancer Med. 2018 02; 7(2):317-324.